tiprankstipranks
ImmunityBio (IBRX)
NASDAQ:IBRX

ImmunityBio (IBRX) Technical Analysis

926 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
ImmunityBio’s (IBRX) Moving Averages Convergence Divergence (MACD) indicator is 0.57, suggesting ImmunityBio is a Buy.
ImmunityBio’s (IBRX) 20-Day exponential moving average is 7.58, while ImmunityBio’s (IBRX) share price is $7.65, making it a Buy.
ImmunityBio’s (IBRX) 50-Day exponential moving average is 6.57, while ImmunityBio’s (IBRX) share price is $7.65, making it a Buy.

ImmunityBio (IBRX) Pivot Points

May 18, 2024, 09:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.04
7.34
7.55
7.85
8.06
8.36
8.57
Fibonacci
7.34
7.54
7.66
7.85
8.05
8.17
8.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ImmunityBio (IBRX) Moving Averages

May 18, 2024, 09:46 PM
Period
Simple
Exponential
MA5
8.11Sell
7.94Sell
MA10
8.07Sell
7.96Sell
MA20
7.60Buy
7.58Buy
MA50
6.32Buy
6.57Buy
MA100
5.31Buy
5.61Buy
MA200
3.89Buy
4.36Buy
ImmunityBio’s (IBRX) 10-Day exponential moving average is 7.96, while ImmunityBio’s (IBRX) share price is $7.65, making it a Sell.
ImmunityBio’s (IBRX) 100-Day exponential moving average is 5.61, while ImmunityBio’s (IBRX) share price is $7.65, making it a Buy.
ImmunityBio’s (IBRX) stock price is $7.65 and ImmunityBio’s (IBRX) 50-day simple moving average is 6.32, creating a Buy signal.
ImmunityBio’s (IBRX) stock price is $7.65 and ImmunityBio’s (IBRX) 100-day simple moving average is 5.31, creating a Buy signal.
ImmunityBio’s (IBRX) stock price is $7.65 and ImmunityBio’s (IBRX) 200-day simple moving average is 3.89, creating a Buy signal.

ImmunityBio (IBRX) Technical Indicators

May 18, 2024, 09:46 PM
Name
Value
Implied Action
RSI (14)
53.14
Neutral
STOCH (9,6)
10.16
Buy
STOCHRSI (14)
24.75
Neutral
MACD (12,26)
0.57
Buy
ADX (14)
33.44
Neutral
Williams %R
-92.19
Buy
CCI (14)
6.25
Neutral
ATR (14)
0.89
-
Ultimate Oscillator
40.82
Neutral
ROC
-14.91
Sell
ImmunityBio’s (IBRX) Relative Strength Index (RSI) is 53.14, creating a Neutral signal.
ImmunityBio’s (IBRX) Trend Strength Indicator (ADX) is 33.44, creating a Neutral signal.
ImmunityBio’s (IBRX) Commodity Channel Index (CCI) is 6.25, creating a Neutral signal.
ImmunityBio’s (IBRX) Price Rate of Change (ROC) is -14.91, creating a Sell signal.

FAQ

Is IBRX a Buy, Hold, or Sell?
Based on IBRX’s technical indicators, IBRX is a Buy.
    What is IBRX’s RSI (14)?
    IBRX’s RSI (14) is 53.14, which suggests IBRX is a Neutral.
      What is IBRX’s MACD?
      IBRX’s MACD is 0.57, which suggests IBRX is a Buy.
        What is IBRX’s 5-day moving average?
        IBRX’s 5-day moving average is 8.11, which suggests IBRX is a Sell.
          What is IBRX’s 20-day moving average?
          IBRX 20-day moving average is 7.60, which suggests IBRX is a Buy.
            What is IBRX’s 50-day moving average?
            IBRX’s 50-day moving average is 6.32, which suggests IBRX is a Buy.
              What is IBRX’s 200-day moving average?
              IBRX’s 200-day moving average is 3.89, which suggests IBRX is a Buy.
                What is IBRX’s Williams % R (14)?
                IBRX’s Williams % R (14) is -92.19, which suggests IBRX is a Buy.
                  What is IBRX’s CCI (14)?
                  IBRX’s CCI (14) is 6.25, which suggests IBRX is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis